Sanders Corazon (corsee) D. - Net Worth and Insider Trading

Over the past 18 months, Sanders Corazon (corsee) D. made 1 insider transaction in BeiGene Ltd (BGNE) with a net sale of 578. Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 4,186 shares made by Julia Aijun Wang , a net sale of 18,252 shares made by Xiaobin Wu , and a net sale of 6,300 shares made by Lai Wang .

In summary, during the past 3 months, insiders sold 15,748 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 15,748 shares. During the past 18 months, 5,457,902 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,457,902 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Sanders Corazon (corsee) D. made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Sanders Corazon (corsee) D. made 4 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 4,391. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 127,853 shares made by Emil D Kakkis , a net sale of 54,366 shares made by Thomas Richard Kassberg , and a net sale of 21,101 shares made by Karah Herdman Parschauer .

In summary, during the past 3 months, insiders sold 32,127 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 32,127 shares. During the past 18 months, 254,161 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 254,161 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.